Chronic vagus nerve stimulation in Crohn's disease: A 6-month follow-up pilot study

Neurogastroenterology and Motility

Volumn 28, Issue 6, 2016, Pages 948-953

  Bonaz, B ^a,b   Sinniger, V ^a,b   Hoffmann, D ^a   Clarencon D ^b   Mathieu, N ^a   Dantzer, C ^c   Vercueil, L ^a   Picq, C ^b   Trocme C ^a   Faure, P ^a   Cracowski, J L ^a   Pellissier, S ^b,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^c UNIVERSITÉ GRENOBLE ALPES   (France)

Author keywords

Cholinergic anti inflammatory pathway; Crohn's disease; Heart rate variability; Vagus nerve; Vagus nerve stimulation

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; INFLIXIMAB;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CROHN DISEASE ENDOSCOPIC INDEX OF SEVERITY; DEPRESSION; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SEVERITY; EVALUATION STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HUMAN; MALE; PAIN; PILOT STUDY; PRIORITY JOURNAL; VAGUS NERVE STIMULATION; VAGUS TONE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; TRENDS; YOUNG ADULT;

ADULT; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; VAGUS NERVE STIMULATION; YOUNG ADULT;

EID: 84961641362     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12792     Document Type: Article

References (22)

1. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013; 144: 36-49.
2. Prechtl JC, Powley TL. The fiber composition of the abdominal vagus of the rat. Anat Embryol (Berl) 1990; 181: 101-15.
3. Fleshner M, Goehler LE, Hermann J, Relton JK, Maier SF, Watkins LR. Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull 1995; 37: 605-10.
4. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
5. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
6. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9.
7. Matteoli G, Boeckxstaens GE. The vagal innervation of the gut and immune homeostasis. Gut 2013; 62: 1214-22.
8. Pellissier S, Dantzer C, Canini F, Mathieu N, Bonaz B. Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome. Psychoneuroendocrinology 2010; 35: 653-62.
9. Pellissier S, Dantzer C, Mondillon L, Trocme C, Gauchez AS, Ducros V, Mathieu N, Toussaint B et al. Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome. PLoS ONE 2014; 9: e105328.
10. Rubio A, Pellissier S, Picot A, Dantzer C, Bonaz B. The link between negative affect, vagal tone, and visceral sensitivity in quiescent Crohn's disease. Neurogastroenterol Motil 2014; 26: 1200-3.
11. Meregnani J, Clarençon D, Vivier M, Peinnequin A, Mouret C, Sinniger V, Picq C, Job A et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 2011; 160: 82-9.
12. Bonaz B, Picq C, Sinniger V, Mayol JF, Clarençon D. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 2013; 25: 208-21.
13. Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV-heart rate variability analysis software. Comput Methods Programs Biomed 2014; 113: 210-20.
14. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. [No authors listed]. Eur Heart J 1996; 17: 354-81.
15. Billman GE. The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 2013; 4: 26.
16. Schirbel A, Reichert A, Roll S, Baumgart DC, Büning C, Wittig B, Wiedenmann B, Dignass A et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 2010; 16: 3168-77.
17. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
18. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989; 30: 983-9.
19. Hébuterne X, Lémann M, Bouhnik Y, Dewit O, Dupas JL, Mross M, D'Haens G, Mitchev K et al. Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol. Gut 2013; 62: 201-8.
20. Morris GL 3rd, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999; 53: 1731-5.
21. Clarençon D, Pellissier S, Sinniger V, Kibleur A, Hoffman D, Vercueil L, David O, Bonaz B. Long term effects of low frequency (10 Hz) vagus nerve stimulation on EEG and heart rate variability in Crohn's disease: a case report. Brain Stimul 2014; 7: 914-6.
22. Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD et al. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy. Epilepsy Behav 2011; 22: 370-5.